Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Terminated 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Pain 4Neoplasms 3Chronic Pain 1Cancer Pain 1Agnosia 1

Interventions

Sodium Chloride 26'-fluoro-4',9'-dihydro-N,N-dimethyl-4-phenylspiro(cyclohexane-1,1'(3'H)-pyrano(3,4-b)indol)-4-amine 2Tapentadol 1Ropivacaine 1Pregabalin 1Meloxicam 1Lidocaine 1Ketorolac Tromethamine 1Ketorolac 1Ketamine 1Fentanyl 1Educational Status 1Anti-Inflammatory Agents, Non-Steroidal 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Chronic Pain × Tapentadol × Clear all
NCT01264887 2019-11-04

Tapentadol in Chronic Malignant Tumour Related Pain

Grünenthal GmbH

Phase 3 Terminated
31 enrolled 19 charts

Agnosia, Neoplasms, Pain, Chronic Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡